CZ20031403A3 - Inhibitor proteasy - Google Patents
Inhibitor proteasy Download PDFInfo
- Publication number
- CZ20031403A3 CZ20031403A3 CZ20031403A CZ20031403A CZ20031403A3 CZ 20031403 A3 CZ20031403 A3 CZ 20031403A3 CZ 20031403 A CZ20031403 A CZ 20031403A CZ 20031403 A CZ20031403 A CZ 20031403A CZ 20031403 A3 CZ20031403 A3 CZ 20031403A3
- Authority
- CZ
- Czechia
- Prior art keywords
- alkyl
- carbon atoms
- group
- substituted
- moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25250800P | 2000-11-22 | 2000-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20031403A3 true CZ20031403A3 (cs) | 2003-10-15 |
Family
ID=22956303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20031403A CZ20031403A3 (cs) | 2000-11-22 | 2001-11-19 | Inhibitor proteasy |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1392657A4 (pt) |
| JP (1) | JP2005513083A (pt) |
| KR (1) | KR20040004445A (pt) |
| CN (1) | CN1635903A (pt) |
| AR (1) | AR034278A1 (pt) |
| AU (1) | AU2001298052A1 (pt) |
| BR (1) | BR0115473A (pt) |
| CA (1) | CA2436850A1 (pt) |
| CZ (1) | CZ20031403A3 (pt) |
| HU (1) | HUP0301964A3 (pt) |
| IL (1) | IL155997A0 (pt) |
| MX (1) | MXPA03004542A (pt) |
| NO (1) | NO20032328L (pt) |
| PL (1) | PL366232A1 (pt) |
| UY (1) | UY27032A1 (pt) |
| WO (1) | WO2003053331A2 (pt) |
| ZA (1) | ZA200303848B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| US7071184B2 (en) | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
| JPWO2008149971A1 (ja) | 2007-06-08 | 2010-08-26 | 日本ケミファ株式会社 | 脳動脈瘤の治療または予防薬 |
| JPWO2009054454A1 (ja) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200101869T2 (tr) * | 1998-12-23 | 2002-01-21 | Smithkline Beecham Corporation | Proteaz İnhibitörleri. |
| US7071184B2 (en) * | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR034278A1 (es) | 2004-02-18 |
| UY27032A1 (es) | 2002-07-31 |
| KR20040004445A (ko) | 2004-01-13 |
| IL155997A0 (en) | 2003-12-23 |
| JP2005513083A (ja) | 2005-05-12 |
| MXPA03004542A (es) | 2003-09-10 |
| AU2001298052A1 (en) | 2003-07-09 |
| NO20032328L (no) | 2003-07-02 |
| PL366232A1 (en) | 2005-01-24 |
| WO2003053331A2 (en) | 2003-07-03 |
| ZA200303848B (en) | 2004-06-28 |
| NO20032328D0 (no) | 2003-05-22 |
| HUP0301964A2 (en) | 2007-02-28 |
| CN1635903A (zh) | 2005-07-06 |
| EP1392657A4 (en) | 2004-03-10 |
| HUP0301964A3 (en) | 2007-09-28 |
| EP1392657A2 (en) | 2004-03-03 |
| CA2436850A1 (en) | 2003-07-03 |
| WO2003053331A3 (en) | 2003-11-13 |
| BR0115473A (pt) | 2004-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7563784B2 (en) | Protease inhibitors | |
| AU2001243441A1 (en) | Protease inhibitors | |
| US20030225061A1 (en) | Protease inhibitors | |
| US7405209B2 (en) | Protease inhibitors | |
| CZ20024086A3 (cs) | Inhibitory proteasy | |
| CZ20031403A3 (cs) | Inhibitor proteasy | |
| WO2000054769A1 (en) | Protease inhibitors | |
| US20050256100A1 (en) | Protease inhibitors | |
| EP1384713B1 (en) | 4-amino-azepan-3-one derivatives as protease inhibitors | |
| US20050256105A1 (en) | Protease inhibitors | |
| US7109233B2 (en) | Protease inhibitors | |
| US20040038965A1 (en) | Protease inhibitors | |
| US20050203084A1 (en) | Protease inhibitors | |
| EP1511492A2 (en) | Protease inhibitors |